Conceptio
›
Archive
›
Europe PMC
Europe PMC
open access
An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol
P A Costa G et al.
Europe PMC · Papers · License: Open Access
Open Source ↗
Direct PDF ↓
biomedical
biomedical, life science
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record
· ID 1133172
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.